UArizona Cancer Researcher Rachna Shroff Dies at 47
The Tucson clinical investigator, who raised $1.3 million for research, passed away from an aggressive cancer.
Updated on Oct. 27, 2026 in Cancer
University of Arizona Cancer Center researcher Rachna Shroff, 47, has died from an aggressive form of cancer. She leaves behind a significant legacy in oncology through her advocacy and clinical investigations.
Why it matters
Dr. Shroff was a key figure in clinical cancer research, and her passing is a loss for the Tucson scientific community. She dedicated her career to advancing investigations that aim to improve patient outcomes.
Dr. Shroff raised $1.3 million to establish a permanent research award. While her clinical focus was widely recognized in oncology, the specific biological nature of the aggressive cancer remains undisclosed.
The players
Rachna Shroff
A researcher who served as the associate director of clinical investigations at the University of Arizona Cancer Center.
University of Arizona Cancer Center
A research institution focused on developing new cancer treatments and improving clinical oncology standards.
The details
Dr. Shroff served as the associate director of clinical investigations at the University of Arizona Cancer Center. In this role, she focused on clinical advancements to better understand and treat complex malignancies, a career path that included a notable presentation at the Gastrointestinal Cancers Symposium in 2021. Her work centered on bridging the gap between innovative research and patient care.
Timeline
2021: Dr. Shroff spoke at the Gastrointestinal Cancers Symposium.
October 30, 2026: The funeral for Dr. Rachna Shroff is scheduled.
Health Landscape
The University of Arizona Cancer Center remains a hub for ongoing clinical trials seeking to improve cancer survival rates. Dr. Shroff's work was a foundational part of this effort, underscoring the vital role individual researchers play in the broader, multi-decade mission to combat malignancy.
This development highlights the importance of supporting clinical trial research, which remains essential for patients navigating aggressive cancer diagnoses. Discussing current research opportunities with your oncologist is a valuable step if you are currently managing a cancer diagnosis.
The takeaway
Dr. Shroff leaves a lasting impact through the $1.3 million endowment she raised to support future oncological research. If you or a loved one are facing an aggressive cancer diagnosis, talk to your physician about the availability of clinical trials in your region.
Further reading
For more on local efforts to advance oncology, visit the Cancer section of our site.
Source note: This article includes information reported by Arizona Public Media.
